An Update from Our Firm about COVID-19

Abraham, Watkins, Nichols, Sorrels, Agosto, Aziz & Stogner remains fully operational and committed to serving our clients and colleagues throughout the Coronavirus (COVID-19) crisis. As we follow the CDC guidelines and practice social distancing, we remain available for phone consultations and scheduled in-person meetings with both current and prospective clients and colleagues. Please contact our office by email or by calling 713-222-7211 with any questions. We look forward to hearing from you.

Ranbaxy Pharmaceuticals Drug Recall

Photo of Randy Sorrels

Dozens of lots of the generic version of the cholesterol drug Lipitor have been recalled because they may contain tiny glass particles. Ranbaxy Pharmaceuticals, a subsidiary of Ranbaxy Laboratories Ltd. is operating under increased scrutiny from the United States Food and Drug Administration (FDA) because of possible multiple quality lapses at several of its factories over the past several years.

This company is a subsidiary of India's biggest drug maker. Besides this recall, the FDA is also alleging that this company has lied about test results for more than 24 of its generic drugs during the past several years. There have also been a string of manufacturing deficiencies that has previously led United States regulators to bar imports of the Indian company's medicines.

On November 23, 2012, Ranbaxy posted a notice on its United States' website indicating it is recalling the 10 -, 20 - and 40 - milligram doses of the tablets atorvastin calcium. This is the generic brand of Lipitor, a drug used to fight cholesterol. Lipitor has been the world's top-selling drug for many years. The website makes it clear that Ranbaxy is proactively recalling these particular drug product lots out of an abundance of caution.

Patients who may believe that their prescription is one of those recalled can contact their pharmacy to help determine whether their prescription was made by Ranbaxy or another generic drug manufacturer, and if it is from Ranbaxy, whether it came from a recalled lot.

If you or someone you know has been harmed by taking a medication, contact the attorneys at Abraham, Watkins, Nichols, Sorrels, Agosto & Friend by calling 713-396-3964 or 1-800-594-4884.

No Comments

Leave a comment
Comment Information
  • $50+ Million Fire & Explosion

    The firm successfully represented nearly 100 victims who suffered personal injuries and damages to property from a large fire and explosion resulting in a settlement of more than $50 million. The firm served as lead lawyers on the steering committee in this litigation.

  • $80 Million Plant Explosion

    The firm successfully represented 270 plaintiffs, taking a lead role in the plaintiffs’ steering committee, who suffered injuries in a large plant explosion resulting in a settlement of nearly $80 million.

  • $50+ Million Plant Fire & Explosion

    The firm successfully represented 45 personal injury victims in a plant fire and explosion, serving on the plaintiffs steering committee, concluding with a settlement of more than $50 million.

  • $22+ Million Worksite Accident

    The firm prevailed in a personal injury trial for a worksite injury client with the jury returning a verdict and resulting in a judgment of over $22 million for the firm’s client.

  • $12 Million 18-Wheeler Collision

    The firm successfully achieved a $12 million settlement for the family of a man who died in an 18 wheeler collision.

  • $48 Million Catastrophic Burns

    The firm prevailed on behalf of three burn victims with settlements totaling nearly $48 million.

Our Record Of Success

When you are hurt and you choose a law firm to represent you in court or at the negotiation table, you need to carefully consider the firm's record.

Read More Success Stories

Let Us Help You Request a Free Consultation Today

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Back to top